A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotype

David J. Daniels, Amol Kulkarni, Zhihua Xie, Rashmi G. Bhushan, Philip S. Portoghese

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotype'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds